Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Véronique Quillien

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Annales De Pathologie|November 6, 2009
[Epigenetic regulation in glioblastomas]Véronique Quillien
Bulletin Du Cancer|November 12, 2003
[Vaccinal cell therapy in melanoma]Véronique Quillien, Thierry Lesimple, Louis Toujas
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 4, 2009
Not all polyriboinosinic-polyribocytidylic acids (Poly I:C) are equivalent for inducing maturation of dendritic cells: implication for alpha-type-1 polarized DCsTony Avril, Marie de Tayrac, Claudine Leberre, et al.
Clinical & Developmental Immunology|October 19, 2010
Overview of cellular immunotherapy for patients with glioblastomaElodie Vauleon, Tony Avril, Brigitte Collet, et al.
Acta Oncologica (Stockholm, Sweden)|January 12, 2019
The potential diagnostic and prognostic role of extracellular vesicles in glioma: current status and future perspectivesZulfikar Azam, Véronique Quillien, Gang Wang, et al.
Immunotherapy|April 29, 2011
Mechanisms of immunomodulation in human glioblastomaTony Avril, Elodie Vauleon, Séverine Tanguy-Royer, et al.
Brain Research|March 27, 2016
Signaling the Unfolded Protein Response in primary brain cancersPierre-Jean Le Reste, Tony Avril, Véronique Quillien, et al.
Brain Research|July 1, 2016
Reprint of: Signaling the Unfolded Protein Response in primary brain cancersPierre-Jean Le Reste, Tony Avril, Véronique Quillien, et al.
Bulletin Du Cancer|April 5, 2011
[MGMT analysis in gliomas]Véronique Quillien, Elodie Vauléon, Stephan Saikali, et al.
Plos One|September 17, 2013
Prognostic significance of EDN/RB, HJURP, p60/CAF-1 and PDLI4, four new markers in high-grade gliomasMarie de Tayrac, Stephan Saikali, Marc Aubry, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Annales De Pathologie|November 6, 2009
[Epigenetic regulation in glioblastomas]Véronique Quillien
Bulletin Du Cancer|November 12, 2003
[Vaccinal cell therapy in melanoma]Véronique Quillien, Thierry Lesimple, Louis Toujas
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 4, 2009
Not all polyriboinosinic-polyribocytidylic acids (Poly I:C) are equivalent for inducing maturation of dendritic cells: implication for alpha-type-1 polarized DCsTony Avril, Marie de Tayrac, Claudine Leberre, et al.
Clinical & Developmental Immunology|October 19, 2010
Overview of cellular immunotherapy for patients with glioblastomaElodie Vauleon, Tony Avril, Brigitte Collet, et al.
Acta Oncologica (Stockholm, Sweden)|January 12, 2019
The potential diagnostic and prognostic role of extracellular vesicles in glioma: current status and future perspectivesZulfikar Azam, Véronique Quillien, Gang Wang, et al.
Immunotherapy|April 29, 2011
Mechanisms of immunomodulation in human glioblastomaTony Avril, Elodie Vauleon, Séverine Tanguy-Royer, et al.
Brain Research|March 27, 2016
Signaling the Unfolded Protein Response in primary brain cancersPierre-Jean Le Reste, Tony Avril, Véronique Quillien, et al.
Brain Research|July 1, 2016
Reprint of: Signaling the Unfolded Protein Response in primary brain cancersPierre-Jean Le Reste, Tony Avril, Véronique Quillien, et al.
Bulletin Du Cancer|April 5, 2011
[MGMT analysis in gliomas]Véronique Quillien, Elodie Vauléon, Stephan Saikali, et al.
Plos One|September 17, 2013
Prognostic significance of EDN/RB, HJURP, p60/CAF-1 and PDLI4, four new markers in high-grade gliomasMarie de Tayrac, Stephan Saikali, Marc Aubry, et al.
Pageof 5